
BioStem Technologies, Inc.: shareholders and insiders
Price
$0.96
November 16, 2026Market cap $18M
Insiders and their shares
Purchases and sales by officers and directors from Aug 9, 2026 to Nov 13, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
- Nov 11, 2026Brandon PoeChief Financial OfficerKind
- Nov 9, 2026Michael A FortunatoChief Accounting OfficerKind
- Nov 1, 2026Barry HassettChief Commercial OfficerKind
- Oct 7, 2026Vurst Andrew Smith-vanChief Operating OfficerKind
- Oct 7, 2026Jason MatuszewskiChief Executive OfficerKind
- Sep 17, 2026Vurst Andrew Smith-vanChief Operating OfficerKind
- Sep 17, 2026Jason MatuszewskiChief Executive OfficerKind
- Sep 15, 2026Brandon PoeChief Financial OfficerKind
- Sep 15, 2026Vurst Andrew Smith-vanChief Operating OfficerKind
- Sep 15, 2026Jason MatuszewskiChief Executive OfficerKind
- Sep 15, 2026Kenneth Howard Warrington JrDirectorKind
- Sep 15, 2026Michael A FortunatoChief Accounting OfficerKind
- Sep 9, 2026Barry HassettChief Commercial OfficerKind
- Aug 27, 2026Jodi UngrodtDirectorKind
- Aug 27, 2026Hannaway Rayna LesserDirectorKind
- Aug 27, 2026Mark A GlickmanDirectorKind
- Aug 27, 2026Kenneth Howard Warrington JrDirectorKind
- Aug 27, 2026Steven D SonenreichDirectorKind
- Aug 11, 2026Brandon PoeChief Financial OfficerKind
- Aug 9, 2026Michael A FortunatoChief Accounting OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Brandon PoeChief Financial Officer | 2,699 | – | – | Form 4 | |
| Nov 9, 2026 | Michael A FortunatoChief Accounting Officer | 970 | – | – | Form 4 | |
| Nov 1, 2026 | Barry HassettChief Commercial Officer | 253 | – | – | Form 4 | |
| Oct 7, 2026 | Vurst Andrew Smith-vanChief Operating Officer | 250.0K | $2.00 | $500.0K | Form 4 | |
| Oct 7, 2026 | Jason MatuszewskiChief Executive Officer | 250.0K | $2.00 | $500.0K | Form 4 | |
| Sep 17, 2026 | Vurst Andrew Smith-vanChief Operating Officer | 9,574 | – | – | Form 4 | |
| Sep 17, 2026 | Jason MatuszewskiChief Executive Officer | 16.7K | – | – | Form 4 | |
| Sep 15, 2026 | Brandon PoeChief Financial Officer | 1,694 | – | – | Form 4 | |
| Sep 15, 2026 | Vurst Andrew Smith-vanChief Operating Officer | 7,622 | – | – | Form 4 | |
| Sep 15, 2026 | Jason MatuszewskiChief Executive Officer | 8,469 | – | – | Form 4 | |
| Sep 15, 2026 | Kenneth Howard Warrington JrDirector | 1,694 | – | – | Form 4 | |
| Sep 15, 2026 | Michael A FortunatoChief Accounting Officer | 4,234 | – | – | Form 4 | |
| Sep 9, 2026 | Barry HassettChief Commercial Officer | 500 | – | – | Form 4 | |
| Aug 27, 2026 | Jodi UngrodtDirector | 5,647 | – | – | Form 4 | |
| Aug 27, 2026 | Hannaway Rayna LesserDirector | 7,671 | – | – | Form 4 | |
| Aug 27, 2026 | Mark A GlickmanDirector | 7,671 | – | – | Form 4 | |
| Aug 27, 2026 | Kenneth Howard Warrington JrDirector | 5,094 | – | – | Form 4 | |
| Aug 27, 2026 | Steven D SonenreichDirector | 7,671 | – | – | Form 4 | |
| Aug 11, 2026 | Brandon PoeChief Financial Officer | 10.6K | – | – | Form 4 | |
| Aug 9, 2026 | Michael A FortunatoChief Accounting Officer | 970 | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Andrew Van VurstShare of class18.4%
- Jason MatuszewskiShare of class17.4%
- The PNC Financial Services Group, Inc.Share of class10.4%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Andrew Van Vurst | 18.4% | 3.85M | Nov 10, 2026 | 13G | |
| Jason Matuszewski | 17.4% | 3.67M | Nov 10, 2026 | 13G | |
| The PNC Financial Services Group, Inc. | 10.4% | 1.94M | Nov 5, 2026 | 13G |
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
No well-known manager
None of the managers we track held BioStem Technologies shares in their latest 13F.
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 333.8K shares were held short, +239.1% since the report before.
- Shares held short
- 333.8K
- Since the report before98.5K on Sep 30, 2026
- +239.1%
- 3.0
- 110.4K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 35%
- Report date
- Oct 15, 2026
- Shares held short
- Aug 14, 2026: Shares held short 554.2K
- Aug 31, 2026: Shares held short 119.2K
- Sep 15, 2026: Shares held short 133.9K
- Sep 30, 2026: Shares held short 98.5K
- Oct 15, 2026: Shares held short 333.8K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading62.8% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 62.8% of the shares in the reported trades were short sales, against 73.4% in the 14 before.
- Last 14 sessionsOct 28, 2026 – Nov 16, 2026
- 62.8%
- The 14 beforeOct 8, 2026 – Oct 27, 2026
- 73.4%
- Change
- -10.6 pts
- Short sales a dayon average, of 218.7K shares
- 137.3K
- More than atof 3,668 US-listed companies, same days
- 88%
- Median of alleight in ten from 34.7% to 63.8%
- 50.3%
- Short sales
- Oct 8, 2026: Short sales 80.9%
- Oct 9, 2026: Short sales 81.7%
- Oct 12, 2026: Short sales 49.5%
- Oct 13, 2026: Short sales 44.1%
- Oct 14, 2026: Short sales 45.4%
- Oct 15, 2026: Short sales 60.5%
- Oct 16, 2026: Short sales 47.4%
- Oct 19, 2026: Short sales 82.8%
- Oct 20, 2026: Short sales 82.2%
- Oct 21, 2026: Short sales 76.6%
- Oct 22, 2026: Short sales 69%
- Oct 23, 2026: Short sales 87.2%
- Oct 26, 2026: Short sales 74.1%
- Oct 27, 2026: Short sales 59.4%
- Oct 28, 2026: Short sales 72.2%
- Oct 29, 2026: Short sales 61.1%
- Oct 30, 2026: Short sales 49.1%
- Nov 2, 2026: Short sales 65.6%
- Nov 3, 2026: Short sales 60.9%
- Nov 4, 2026: Short sales 69.9%
- Nov 5, 2026: Short sales 50.8%
- Nov 6, 2026: Short sales 46.9%
- Nov 9, 2026: Short sales 44.3%
- Nov 10, 2026: Short sales 60.8%
- Nov 11, 2026: Short sales 68.4%
- Nov 12, 2026: Short sales 55.7%
- Nov 13, 2026: Short sales 73.5%
- Nov 16, 2026: Short sales 47.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Vurst Andrew Smith-vanChief Operating OfficerDirectly1.79M
- Jason MatuszewskiChief Executive OfficerDirectly1.55M
- Michael A FortunatoChief Accounting OfficerDirectly69.6K
- Brandon PoeChief Financial OfficerDirectly60.8K
- Kenneth Howard Warrington JrDirectorDirectly33.9K
- Jodi UngrodtDirectorDirectly11.3K
- Hannaway Rayna LesserDirectorDirectly7,671
- Mark A GlickmanDirectorDirectly7,671
- Steven D SonenreichDirectorDirectly7,671
- Barry HassettChief Commercial OfficerDirectly5,256
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Vurst Andrew Smith-vanChief Operating Officer | 1.79M | – | Oct 7, 2026 | Form 4 |
| Jason MatuszewskiChief Executive Officer | 1.55M | – | Oct 7, 2026 | Form 4 |
| Michael A FortunatoChief Accounting Officer | 69.6K | – | Nov 9, 2026 | Form 4 |
| Brandon PoeChief Financial Officer | 60.8K | – | Nov 11, 2026 | Form 4 |
| Kenneth Howard Warrington JrDirector | 33.9K | – | Sep 15, 2026 | Form 4 |
| Jodi UngrodtDirector | 11.3K | – | Aug 27, 2026 | Form 4 |
| Hannaway Rayna LesserDirector | 7,671 | – | Aug 27, 2026 | Form 4 |
| Mark A GlickmanDirector | 7,671 | – | Aug 27, 2026 | Form 4 |
| Steven D SonenreichDirector | 7,671 | – | Aug 27, 2026 | Form 4 |
| Barry HassettChief Commercial Officer | 5,256 | – | Nov 1, 2026 | Form 4 |
A lower bound: it counts only the 10 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
Have BSEM's insiders bought or sold?
From Aug 20, 2026 to Nov 13, 2026 BioStem Technologies's insiders reported no purchase or sale of shares on the market.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.